論文

査読有り 国際誌
2020年11月

Seroepidemiological analysis of anti-pneumococcal surface protein A (PspA) immunoglobulin G by clades in Japanese population

Vaccine
  • Saeko Morino
  • ,
  • Etsuko Kitagami
  • ,
  • Hiroki Nakayama
  • ,
  • Yuka Koizumi
  • ,
  • Keiko Tanaka-Taya
  • ,
  • Yuki Kinjo
  • ,
  • Kazunori Oishi

38
47
開始ページ
7479
終了ページ
7484
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.vaccine.2020.09.068
出版者・発行元
Elsevier BV

BACKGROUND: Pneumococcal surface protein A (PspA) is one of the candidates of the novel pneumococcal protein vaccines. The seroepidemiology of naturally acquired anti-PspA immunoglobulin G (IgG) by clades, across a wide range of ages has not been investigated. METHODS: We examined the concentrations of anti-PspA IgG by clades (1, 2, 3, 4, and 5) in 397 sera from persons aged 0-≥70 years by enzyme-linked immunosorbent assay, and determined the geometric mean concentrations (GMCs) by age group. The relationships between concentrations of anti-PspA IgG antibody for each clade for each person were also assessed. RESULTS: GMC of anti-PspA IgG was lowest, highest, and plateaued in those aged 6-11 months, 5-9-years, and 20-49 years, respectively. It gradually declined in those aged > 70 years. GMCs patterns in different age groups were similar for all clades. Correlations were found especially within the same PspA family (between clades 1 and 2 or clades 4 and 5). CONCLUSIONS: Our data suggested that most people acquired anti-PspA IgG across clades 1, 2, 3, 4, and 5 during childhood. These results would be a fundamental data of clade-specific anti-PspA IgG antibodies.

リンク情報
DOI
https://doi.org/10.1016/j.vaccine.2020.09.068
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33039208
ID情報
  • DOI : 10.1016/j.vaccine.2020.09.068
  • ISSN : 0264-410X
  • PubMed ID : 33039208

エクスポート
BibTeX RIS